SCHEMBL2567382

SCHEMBL2567382

O=C(COCC1CCCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N1CCN(c2ccccc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.58
ALDH1A1 P00352 3/20 0.58
USP2 O75604 1/20 0.58
GAA P10253 1/20 0.58
SMN1; SMN2 Q16637 3/20 0.53
HTT P42858 2/20 0.53
KMT2A Q03164 3/20 0.47
TSHR P16473 2/20 0.47
MEN1 O00255 2/20 0.45
POLB P06746 2/20 0.45
GRM5 P41594 3/20 0.44
HTR7 P34969 2/20 0.44
HTR1A P08908 1/20 0.44
DRD2 P14416 1/20 0.44
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44
HTR1E P28566 1/20 0.44
ADRA1B P35368 1/20 0.44
DRD3 P35462 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2568310 0.97 ALDH1A1 (0.57) LMNAALDH1A1USP2GAASMN1; SMN2
SCHEMBL2569471 0.91 SMN1; SMN2 (0.48) LMNAALDH1A1USP2GAASMN1; SMN2
SCHEMBL2564967 0.90 LMNA (0.47) LMNAALDH1A1USP2GAASMN1; SMN2
SCHEMBL2568679 0.90 ALDH1A1 (0.47) LMNAALDH1A1USP2GAASMN1; SMN2
SCHEMBL2563706 0.87 ALDH1A1 (0.51) LMNAALDH1A1USP2GAAKMT2A
SCHEMBL2566099 0.86 HTR7 (0.52) LMNAALDH1A1USP2GAAKMT2A
SCHEMBL2570681 0.85 TSHR (0.49) KMT2ATSHRMEN1HTR7HTR1A
SCHEMBL2568747 0.84 GRIN1 (0.45) LMNAALDH1A1USP2GAASMN1; SMN2
SCHEMBL2563882 0.84 TSHR (0.49) LMNAALDH1A1USP2GAAKMT2A
SCHEMBL5088383 0.84 TSHR (0.54) GAASMN1; SMN2KMT2ATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066659-B1 SUBSTITUTED SULFONAMIDE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-08-28 EP claimed
EP-2383267-A1 Substituted sulfonamide derivatives Grünenthal GmbH (DE) 2011-11-02 EP claimed
US-20100317644-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-16 US claimed
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2008-06-26 US claimed
EP-2066659-B1 SUBSTITUTED SULFONAMIDE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-08-28 EP disclosed
US-8435978-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2013-05-07 US disclosed
EP-2383267-A1 Substituted sulfonamide derivatives Grünenthal GmbH (DE) 2011-11-02 EP disclosed
US-20100324009-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-23 US disclosed
US-20100317644-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-16 US disclosed
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317644-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 LMNA 2964/4885ALDH1A1 1535/4885USP2 2278/4885
US-20100324009-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 LMNA 2964/4885ALDH1A1 1535/4885USP2 2278/4885
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS SULT2A1, STS, SULT1A1 LMNA 2964/4885ALDH1A1 1535/4885USP2 2278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.